Biden’s NSC Intel Director, Maher Bitar, Is a Former Radical Pro-Palestinian Activst
Maher Bitar, a senior White House intel officia, is a former pro-Palestinian activist who was a leader in Students for Justice in Palestine.
Maher Bitar, a senior White House intel officia, is a former pro-Palestinian activist who was a leader in Students for Justice in Palestine.
Patients with RCC who experience disease recurrence after adjuvant IO benefit from subsequent systemic therapies.
The SWENOTECA cancer care program sought to evaluate survival, toxicity in patients treated with HDCT from 2011 through 2021.
AI patient navigator MyEleanor re-engages underserved patients who miss initial colonoscopy screening appointments, increasing the colonoscopy completion rate from 10% to 19% (Abstract 100).
Studies of cancer drugs often use terms that downplay the seriousness of adverse events. Bishal Gyawali and colleagues call for greater clarity and transparency The…
Updates CORE-001 trial results examined cretostimogene with pembrolizumab for the treatment of high-risk NMIBC with CIS in patients who are unresponsive to BCG therapy.
In this study, higher adherence to the Mediterranean diet was associated with one-fifth lower relative risk of mortality, which could be partially explained by
In this executive editor’s message, Elias Jabbour, MD, writes about redefining leukemias as curable or less curable.
Giuseppe Curigliano University of Milan and European Institute of Oncology, IRCCS Giuseppe Curigliano, Xichun Hu, Rebecca Dent, Kan Yonemori, Carlos Barrios, Joyce O’Shaughnessy, Hans Wildiers,…
Find key news and updates for oncology nurses from the American Society of Clinical Oncology 2024 Annual Meeting.
Dr. Julie Gralow, ASCO’s chief medical officer, provides a first look at the 5 Plenary abstracts from the 2024 ASCO Annual Meeting.